PLURI

About PLURI

Pluri (Nasdaq: PLUR) is a biotechnology leader specializing in mass-scale cell expansion. In 2026, the company commercializes exosome-based technologies across aesthetic medicine and sustainable bio-farming, leveraging its 3D cell-expansion platform to produce lab-grown coffee and cacao.